These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31364369)

  • 21. Disentangling the association of depression on the anti-fatigue effects of ketamine.
    Saligan LN; Farmer C; Ballard ED; Kadriu B; Zarate CA
    J Affect Disord; 2019 Feb; 244():42-45. PubMed ID: 30312839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight.
    Singh I; Morgan C; Curran V; Nutt D; Schlag A; McShane R
    Lancet Psychiatry; 2017 May; 4(5):419-426. PubMed ID: 28395988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants.
    Rotroff DM; Corum DG; Motsinger-Reif A; Fiehn O; Bottrel N; Drevets WC; Singh J; Salvadore G; Kaddurah-Daouk R
    Transl Psychiatry; 2016 Sep; 6(9):e894. PubMed ID: 27648916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ketamine treatment on suicidal ideation: a qualitative study of patients' accounts following treatment for depression in a UK ketamine clinic.
    Lascelles K; Marzano L; Brand F; Trueman H; McShane R; Hawton K
    BMJ Open; 2019 Aug; 9(8):e029108. PubMed ID: 31420388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study.
    Cullen KR; Amatya P; Roback MG; Albott CS; Westlund Schreiner M; Ren Y; Eberly LE; Carstedt P; Samikoglu A; Gunlicks-Stoessel M; Reigstad K; Horek N; Tye S; Lim KO; Klimes-Dougan B
    J Child Adolesc Psychopharmacol; 2018 Sep; 28(7):437-444. PubMed ID: 30004254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketamine: Future Treatment For Unresponsive Depression?
    Frere M; Tepper J
    Ir Med J; 2016 Sep; 109(8):453. PubMed ID: 28124853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ameliorating treatment-refractory depression with intranasal ketamine: potential NMDA receptor actions in the pain circuitry representing mental anguish.
    Opler LA; Opler MG; Arnsten AF
    CNS Spectr; 2016 Feb; 21(1):12-22. PubMed ID: 25619798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Repeated Intravenous Ketamine in Treatment-Resistant Geriatric Depression: A Case Series.
    Bryant KA; Altinay M; Finnegan N; Cromer K; Dale RM
    J Clin Psychopharmacol; 2019; 39(2):158-161. PubMed ID: 30742589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoting the Discussion of the Beneficial Effects of Ketamine to Treat Refractory Depression.
    Ghosh P; Viswanath O
    Psychopharmacol Bull; 2019 Feb; 49(1):98-99. PubMed ID: 30858644
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of suicidal depression with ketamine in rapid cycling bipolar disorder.
    Sampath H; Sharma I; Dutta S
    Asia Pac Psychiatry; 2016 Mar; 8(1):98-101. PubMed ID: 26871425
    [No Abstract]   [Full Text] [Related]  

  • 31. Ketamine for Treatment-Resistant Depression: A Gateway to Novel Treatment Approaches.
    Limandri BJ
    J Psychosoc Nurs Ment Health Serv; 2018 Oct; 56(10):11-14. PubMed ID: 30278095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant benzodiazepine use attenuates ketamine response: implications for large scale study design and clinical development.
    Frye MA; Blier P; Tye SJ
    J Clin Psychopharmacol; 2015 Jun; 35(3):334-6. PubMed ID: 25928701
    [No Abstract]   [Full Text] [Related]  

  • 33. Off-label use of ketamine for treatment-resistant depression in clinical practice: European perspective.
    López-Díaz Á; Murillo-Izquierdo M; Moreno-Mellado E
    Br J Psychiatry; 2019 Aug; 215(2):447-448. PubMed ID: 31030677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is ketamine ready to be used clinically for the treatment of depression?
    Loo C
    Med J Aust; 2015 Dec; 203(11):425. PubMed ID: 26654603
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment-refractory depression: a case of successful treatment with intranasal ketamine 10%.
    Clark P
    Ann Clin Psychiatry; 2014 May; 26(2):145. PubMed ID: 24501735
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder.
    Murrough JW; Collins KA; Fields J; DeWilde KE; Phillips ML; Mathew SJ; Wong E; Tang CY; Charney DS; Iosifescu DV
    Transl Psychiatry; 2015 Feb; 5(2):e509. PubMed ID: 25689570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunomodulatory effect of ketamine in depression.
    Szałach ŁP; Lisowska KA; Słupski J; Włodarczyk A; Górska N; Szarmach J; Jakuszkowiak-Wojten K; Gałuszko-Węgielnik M; Wiglusz MS; Wilkowska A; Cubała WJ
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):252-257. PubMed ID: 31488736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment escalation in patients not responding to pharmacotherapy, psychotherapy, and electro-convulsive therapy: experiences from a novel regimen using intravenous S-ketamine as add-on therapy in treatment-resistant depression.
    Kallmünzer B; Volbers B; Karthaus A; Tektas OY; Kornhuber J; Müller HH
    J Neural Transm (Vienna); 2016 May; 123(5):549-52. PubMed ID: 26721476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Esketamine clinical trials: reply to Maju
    Gastaldon C; Papola D; Ostuzzi G; Barbui C
    Epidemiol Psychiatr Sci; 2020 Apr; 29():e122. PubMed ID: 32345395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase in PAS-induced neuroplasticity after a treatment course of intranasal ketamine for depression. Report of three cases from a placebo-controlled trial.
    Gálvez V; Nikolin S; Ho KA; Alonzo A; Somogyi AA; Loo CK
    Compr Psychiatry; 2017 Feb; 73():31-34. PubMed ID: 27886522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.